Kathy S. Albain, MD

Kathy S. Albain, MD

Medicine

Hematology/Oncology
Professor

Languages Spoken

English

Clinical Expertise

  • Breast Cancer
  • Chemoprevention Of Breast Cancer
  • Chemoprevention Of Lung Cancer
  • Lung Cancer

About Dr. Albain

Interests
Classical Music, Travel, Family/Friends, Bicycling, Reading, Pipe Organ, Hiking, Singing, Exercise

Medical Education

Medical School
University of Michigan Medical School
Residency
University of Illinois at Chicago Medical Center - Internal Medicine: General
Fellowship
  • University of Chicago Hospitals and Clinics - Internal Medicine: Hematology & Medical Oncology

Board Certification

American Board of Internal Medicine Subspecialty Medical Oncology

Research

  • Genome-wide meta-analyses identifies novel taxane-induced peripheral neuropathy-associated loci Sucheston-Campbell, L. E.; Clay-Gilmour, A. I.; Barlow, W. E.; Budd, G. T.; Stram, D. O.; Haiman, C. A.; Sheng, X.; Yan, L.; Zirpoli, G.; Yao, S.; Jiang, C.; Owzar, K.; Hershman, D.; Albain, K. S.; Hayes, D. F.; Moore, H. C.; Hobday, T. J.; Stewart, J. A.; Rizvi, A.; Isaacs, C.; Salim, M.; Gralow, J. R.; Hortobagyi, G. N.; Livingston, R. B.; Kroetz, D. L.; Ambrosone, C. B., Pharmacogenetics and Genomics
  • Smoking Sex, and Non-Small Cell Lung Cancer: Steroid Hormone Receptors in Tumor Tissue (S0424), Cheng, T. D.; Darke, A. K.; Redman, M. W.; Zirpoli, G. R.; Davis, W.; Payne Ondracek, R.; Bshara, W.; Omilian, A. R.; Kratzke, R.; Reid, M. E.; Molina, J. R.; Kolesar, J. M.; Chen, Y.; MacRae, R. M.; Moon, J.; Mack, P.; Gandara, D. R.; Kelly, K.; Santella, R. M.; Albain, K. S.; Ambrosone, C. B., Journal of the National Cancer Institute
  • Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715) Hershman, D. L.; Unger, J. M.; Crew, K. D.; Till, C.; Greenlee, H.; Minasian, L. M.; Moinpour, C. M.; Lew, D. L.; Fehrenbacher, L.; Wade, J. L., 3rd; Wong, S. F.; Fisch, M. J.; Lynn Henry, N.; Albain, K. S., Journal of the National Cancer Institute
View All ResearchShow Less
  • How do we increase uptake of tamoxifen and other anti-estrogens for breast cancer prevention? Crew, K. D.; Albain, K. S.; Hershman, D. L.; Unger, J. M.; Lo, S. S., NPJ breast cancer
  • Supplement Use and Chemotherapy-Induced Peripheral Neuropathy in a Cooperative Group Trial (S0221): The DELCaP Study Zirpoli, G. R.; McCann, S. E.; Sucheston-Campbell, L. E.; Hershman, D. L.; Ciupak, G.; Davis, W.; Unger, J. M.; Moore, H. C. F.; Stewart, J. A.; Isaacs, C.; Hobday, T. J.; Salim, M.; Hortobagyi, G. N.; Gralow, J. R.; Budd, G. T.; Albain, K. S.; Ambrosone, C. B., Journal of the National Cancer Institute
  • Adaptive Randomization of Neratinib in Early Breast Cancer Park, J. W.; Liu, M. C.; Yee, D.; Yau, C.; van 't Veer, L. J.; Symmans, W. F.; Paoloni, M.; Perlmutter, J.; Hylton, N. M.; Hogarth, M.; DeMichele, A.; Buxton, M. B.; Chien, A. J.; Wallace, A. M.; Boughey, J. C.; Haddad, T. C.; Chui, S. Y.; Kemmer, K. A.; Kaplan, H. G.; Isaacs, C.; Nanda, R.; Tripathy, D.; Albain, K. S.; Edmiston, K. K.; Elias, A. D.; Northfelt, D. W.; Pusztai, L.; Moulder, S. L.; Lang, J. E.; Viscusi, R. K.; Euhus, D. M.; Haley, B. B.; Khan, Q. J.; Wood, W. C.; Melisko, M.; Schwab, R.; Helsten, T.; Lyandres, J.; Davis, S. E.; Hirst, G. L.; Sanil, A.; Esserman, L. J.; Berry, D. A.; I-SPY 2 Investigators, The New England journal of medicine
  • Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer Rugo, H. S.; Olopade, O. I.; DeMichele, A.; Yau, C.; van 't Veer, L. J.; Buxton, M. B.; Hogarth, M.; Hylton, N. M.; Paoloni, M.; Perlmutter, J.; Symmans, W. F.; Yee, D.; Chien, A. J.; Wallace, A. M.; Kaplan, H. G.; Boughey, J. C.; Haddad, T. C.; Albain, K. S.; Liu, M. C.; Isaacs, C.; Khan, Q. J.; Lang, J. E.; Viscusi, R. K.; Pusztai, L.; Moulder, S. L.; Chui, S. Y.; Kemmer, K. A.; Elias, A. D.; Edmiston, K. K.; Euhus, D. M.; Haley, B. B.; Nanda, R.; Northfelt, D. W.; Tripathy, D.; Wood, W. C.; Ewing, C.; Schwab, R.; Lyandres, J.; Davis, S. E.; Hirst, G. L.; Sanil, A.; Berry, D. A.; Esserman, L. J.; I-SPY 2 Investigators, The New England journal of medicine
  • Fulvestrant decreases anastrozole drug concentrations when taken concurrently by patients with metastatic breast cancer treated on SWOG study S0226 Hertz, D. L.; Barlow, W. E.; Kidwell, K. M.; Albain, K. S.; Vandenberg, T. A.; Dakhil, S. R.; Tirumali, N. R.; Livingston, R. B.; Gralow, J.; Hayes, D. F.; Hortobagyi, G. N.; Mehta, R. S.; Rae, J. M., BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
  • Randomized trial of medroxyprogesterone acetate for the prevention of endometrial pathology from adjuvant tamoxifen for breast cancer: SWOG S9630 Potkul, R. K.; Unger, J. M.; Livingston, R. B.; Crew, K. D.; Wilczynski, S. P.; Salomon, C. G.; Smith, B. L.; Wong, L.; Campbell, D. L.; Einspahr, D. E.; Anderson, G. L.; Hershman, D.; Goodman, G. E.; Brown, P. H.; Meyskens, F. L.; Albain, K. S., NPJ breast cancer
  • Adjuvant paclitaxel and trastuzumab for node-negative HER2-positive breast cancer, Tolaney, S. M.; Barry, W. T.; Dang, C. T.; Yardley, D. A.; Moy, B.; Marcom, P. K.; Albain, K. S.; Rugo, H. S.; Ellis, M.; Shapira, I.; Wolff, A. C.; Carey, L. A.; Overmoyer, B. A.; Partridge, A. H.; Guo, H.; Hudis, C. A.; Krop, I. E.; Burstein, H. J.; Winer, E. P., The New England journal of medicine
  • Cardiac Outcomes of Patients Receiving Adjuvant Weekly Paclitaxel and Trastuzumab for Node-Negative ERBB2-Positive Breast Cancer, Dang, C.; Guo, H.; Najita, J.; Yardley, D.; Marcom, K.; Albain, K.; Rugo, H.; Miller, K.; Ellis, M.; Shapira, I.; Wolff, A. C.; Carey, L. A.; Moy, B.; Groarke, J.; Moslehi, J.; Krop, I.; Burstein, H. J.; Hudis, C.; Winer, E. P.; Tolaney, S. M., JAMA oncology
  • Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy Moore, H. C.; Unger, J. M.; Phillips, K. A.; Boyle, F.; Hitre, E.; Porter, D.; Francis, P. A.; Goldstein, L. J.; Gomez, H. L.; Vallejos, C. S.; Partridge, A. H.; Dakhil, S. R.; Garcia, A. A.; Gralow, J.; Lombard, J. M.; Forbes, J. F.; Martino, S.; Barlow, W. E.; Fabian, C. J.; Minasian, L.; Meyskens, F. L., Jr; Gelber, R. D.; Hortobagyi, G. N.; Albain, K. S.; POEMS/S0230 Investigators, The New England journal of medicine
  • Patient Income Level and Cancer Clinical Trial Participation: A Prospective Survey Study Unger, J. M.; Gralow, J. R.; Albain, K. S.; Ramsey, S. D.; Hershman, D. L., JAMA oncology
  • PKCalpha Attenuates Jagged-1-Mediated Notch Signaling in ErbB-2-Positive Breast Cancer to Reverse Trastuzumab Resistance Pandya, K.; Wyatt, D.; Gallagher, B.; Shah, D.; Baker, A.; Bloodworth, J.; Zlobin, A.; Pannuti, A.; Green, A.; Ellis, I. O.; Filipovic, A.; Sagert, J.; Rana, A.; Albain, K. S.; Miele, L.; Denning, M. F.; Osipo, C., Clinical cancer research : an official journal of the American Association for Cancer Research
  • Prospective Validation of a 21-Gene Expression Assay in Breast Cancer Sparano, J. A.; Gray, R. J.; Makower, D. F.; Pritchard, K. I.; Albain, K. S.; Hayes, D. F.; Geyer, C. E., Jr; Dees, E. C.; Perez, E. A.; Olson, J. A., Jr; Zujewski, J.; Lively, T.; Badve, S. S.; Saphner, T. J.; Wagner, L. I.; Whelan, T. J.; Ellis, M. J.; Paik, S.; Wood, W. C.; Ravdin, P.; Keane, M. M.; Gomez Moreno, H. L.; Reddy, P. S.; Goggins, T. F.; Mayer, I. A.; Brufsky, A. M.; Toppmeyer, D. L.; Kaklamani, V. G.; Atkins, J. N.; Berenberg, J. L.; Sledge, G. W., The New England journal of medicine
  • SWOG S0221: a phase III trial comparing chemotherapy schedules in high-risk early-stage breast cancer Budd, G. T.; Barlow, W. E.; Moore, H. C.; Hobday, T. J.; Stewart, J. A.; Isaacs, C.; Salim, M.; Cho, J. K.; Rinn, K. J.; Albain, K. S.; Chew, H. K.; Burton, G. V.; Moore, T. D.; Srkalovic, G.; McGregor, B. A.; Flaherty, L. E.; Livingston, R. B.; Lew, D. L.; Gralow, J. R.; Hortobagyi, G. N., Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • The Neoadjuvant Model is Still the Future for Drug Development in Breast Cancer DeMichele, A.; Yee, D.; Berry, D. A.; Albain, K. S.; Benz, C. C.; Boughey, J.; Buxton, M.; Chia, S. K.; Chien, A. J.; Chui, S. Y.; Clark, A.; Edmiston, K.; Elias, A.; Forero-Torres, A.; Haddad, T. C.; Haley, B.; Haluska, P.; Hylton, N. M.; Isaacs, C.; Kaplan, H.; Korde, L. A.; Leyland-Jones, B.; Liu, M. C.; Melisko, M.; Minton, S. E.; Moulder, S.; Nanda, R.; Olopade, O. I.; Paoloni, M.; Park, J. W.; Parker, B. A.; Perlmutter, J.; Petricoin, E., 3rd; Rugo, H. S.; Symmans, W. F.; Tripathy, D.; van 't Veer, L. J.; Viscusi, R. K.; Wallace, A.; Wolf, D.; Yau, C.; Esserman, L. J., Clinical cancer research : an official journal of the American Association for Cancer Research
  • Phase IIa trial of trastuzumab emtansine with pertuzumab for patients with human epidermal growth factor receptor 2-positive locally advanced, or metastatic breast cancer, Miller, K. D.; Dieras, V.; Harbeck, N.; Andre, F.; Mahtani, R. L.; Gianni, L.; Albain, K. S.; Crivellari, D.; Fang, L.; Michelson, G.; de Haas, S. L.; Burris, H. A., Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Positron emission tomography-avid adrenal mass and incidental renal mass in a 70-year-old woman with newly diagnosed breast cancer Hannick, J. H.; Wang, L.; Barkan, G. A.; Perez, C.; Bova, D.; Albain, K. S.; Quek, M. L., Urology
  • Developing safety criteria for introducing new agents into neoadjuvant trials DeMichele, A.; Berry, D. A.; Zujewski, J.; Hunsberger, S.; Rubinstein, L.; Tomaszewski, J. E.; Kelloff, G.; Perlmutter, J.; Buxton, M.; Lyandres, J.; Albain, K. S.; Benz, C.; Chien, A. J.; Haluska, P.; Leyland-Jones, B.; Liu, M. C.; Munster, P.; Olopade, O.; Park, J. W.; Parker, B. A.; Pusztai, L.; Tripathy, D.; Rugo, H.; Yee, D.; Esserman, L., Clinical cancer research : an official journal of the American Association for Cancer Research
  • Patient income level and cancer clinical trial participation Unger, J. M.; Hershman, D. L.; Albain, K. S.; Moinpour, C. M.; Petersen, J. A.; Burg, K.; Crowley, J. J., Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Randomized Double-Blind Placebo-Controlled Trial of Acetyl-L-Carnitine for the Prevention of Taxane-Induced Neuropathy in Women Undergoing Adjuvant Breast Cancer Therapy Hershman, D. L.; Unger, J. M.; Crew, K. D.; Minasian, L. M.; Awad, D.; Moinpour, C. M.; Hansen, L.; Lew, D. L.; Greenlee, H.; Fehrenbacher, L.; Wade, J. L., 3rd; Wong, S. F.; Hortobagyi, G. N.; Meyskens, F. L.; Albain, K. S., Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Supplement use during an intergroup clinical trial for breast cancer (S0221) Zirpoli, G. R.; Brennan, P. M.; Hong, C. C.; McCann, S. E.; Ciupak, G.; Davis, W.; Unger, J. M.; Budd, G. T.; Hershman, D. L.; Moore, H. C.; Stewart, J.; Isaacs, C.; Hobday, T.; Salim, M.; Hortobagyi, G. N.; Gralow, J. R.; Albain, K. S.; Ambrosone, C. B., Breast cancer research and treatment
  • A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316) Javid, S. H.; Unger, J. M.; Gralow, J. R.; Moinpour, C. M.; Wozniak, A. J.; Goodwin, J. W.; Lara, P. N., Jr; Williams, P. A.; Hutchins, L. F.; Gotay, C. C.; Albain, K. S., The oncologist
  • Choosing the best trastuzumab-based adjuvant chemotherapy regimen: should we abandon anthracyclines? Burstein, H. J.; Piccart-Gebhart, M. J.; Perez, E. A.; Hortobagyi, G. N.; Wolmark, N.; Albain, K. S.; Norton, L.; Winer, E. P.; Hudis, C. A., Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Combination anastrozole and fulvestrant in metastatic breast cancer Mehta, R. S.; Barlow, W. E.; Albain, K. S.; Vandenberg, T. A.; Dakhil, S. R.; Tirumali, N. R.; Lew, D. L.; Hayes, D. F.; Gralow, J. R.; Livingston, R. B.; Hortobagyi, G. N., The New England journal of medicine
  • Evaluating health-related quality-of-life therapeutic effectiveness in a clinical trial with extensive nonignorable missing data and heterogeneous response: results from a phase III randomized trial of gemcitabine plus paclitaxel versus paclitaxel monotherapy in patients with metastatic breast cancer Moinpour, C. M.; Donaldson, G. W.; Liepa, A. M.; Melemed, A. S.; O'Shaughnessy, J.; Albain, K. S., Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
  • Multicenter double-blind, placebo-controlled, randomized phase II trial of gemcitabine/cisplatin plus bevacizumab or placebo in patients with malignant mesothelioma, Kindler, H. L.; Karrison, T. G.; Gandara, D. R.; Lu, C.; Krug, L. M.; Stevenson, J. P.; Janne, P. A.; Quinn, D. I.; Koczywas, M. N.; Brahmer, J. R.; Albain, K. S.; Taber, D. A.; Armato, S. G., 3rd; Vogelzang, N. J.; Chen, H. X.; Stadler, W. M.; Vokes, E. E., Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Phase II trial of simple oral therapy with capecitabine and cyclophosphamide in patients with metastatic breast cancer: SWOG S0430 Schott, A. F.; Barlow, W. E.; Albain, K. S.; Chew, H. K.; Wade, J. L., 3rd; Lanier, K. S.; Lew, D. L.; Hayes, D. F.; Gralow, J. R.; Livingston, R. B.; Hortobagyi, G. N., The oncologist
  • Commentary on adjuvant chemotherapy for the older woman with early stage breast cancer Albain, K. S., Breast (Edinburgh, Scotland)
  • Genetic predictors of taxane-induced neurotoxicity in a SWOG phase III intergroup adjuvant breast cancer treatment trial (S0221) Sucheston, L. E.; Zhao, H.; Yao, S.; Zirpoli, G.; Liu, S.; Barlow, W. E.; Moore, H. C.; Thomas Budd, G.; Hershman, D. L.; Davis, W.; Ciupak, G. L.; Stewart, J. A.; Isaacs, C.; Hobday, T. J.; Salim, M.; Hortobagyi, G. N.; Gralow, J. R.; Livingston, R. B.; Albain, K. S.; Hayes, D. F.; Ambrosone, C. B., Breast cancer research and treatment
  • Impact of Multigene Assays in Early Stage Breast Cancer Lo, S. S.; Albain, K. S., Oncologist
  • Phase II study of sunitinib as maintenance therapy in patients with locally advanced or metastatic non-small cell lung cancer Gervais, R.; Hainsworth, J. D.; Blais, N.; Besse, B.; Laskin, J.; Hamm, J. T.; Lipton, A.; Albain, K. S.; Masters, G. A.; Natale, R. B.; Selaru, P.; Kim, S. T.; Chao, R. C.; Page, R. D., Lung cancer (Amsterdam, Netherlands)
  • SWOG S0215: a phase II study of docetaxel and vinorelbine plus filgrastim with weekly trastuzumab for HER2-positive stage IV breast cancer, Livingston, R. B.; Barlow, W. E.; Kash, J. J.; Albain, K. S.; Gralow, J. R.; Lew, D. L.; Flaherty, L. E.; Royce, M. E.; Hortobagyi, G. N., Breast cancer research and treatment
  • Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence. Pandya, K.; Meeke, K.; Clementz, A. G.; Rogowski, A.; Roberts, J.; Miele, L.; Albain, K. S.; Osipo, C., British journal of cancer
  • A multicenter phase 2 study of vascular endothelial growth factor trap (Aflibercept) in platinum- and erlotinib-resistant adenocarcinoma of the lung, Leighl, N. B.; Raez, L. E.; Besse, B.; Rosen, P. J.; Barlesi, F.; Massarelli, E.; Gabrail, N.; Hart, L. L.; Albain, K. S.; Berkowitz, L.; Melnyk, O.; Shepherd, F. A.; Sternas, L.; Ackerman, J.; Shun, Z.; Miller, V. A.; Herbst, R. S., Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
  • Cyclophosphamide epirubicin, and Fluorouracil versus dose-dense epirubicin and cyclophosphamide followed by Paclitaxel versus Doxorubicin and cyclophosphamide followed by Paclitaxel in node-positive or high-risk node-negative breast cancer, Burnell, M.; Levine, M. N.; Chapman, J. A.; Bramwell, V.; Gelmon, K.; Walley, B.; Vandenberg, T.; Chalchal, H.; Albain, K. S.; Perez, E. A.; Rugo, H.; Pritchard, K.; O'Brien, P.; Shepherd, L. E., Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Gene polymorphisms in cyclophosphamide metabolism pathway treatment-related toxicity, and disease-free survival in SWOG 8897 clinical trial for breast cancer, Yao, S.; Barlow, W. E.; Albain, K. S.; Choi, J. Y.; Zhao, H.; Livingston, R. B.; Davis, W.; Rae, J. M.; Yeh, I. T.; Hutchins, L. F.; Ravdin, P. M.; Martino, S.; Lyss, A. P.; Osborne, C. K.; Abeloff, M.; Hortobagyi, G. N.; Hayes, D. F.; Ambrosone, C. B., Clinical cancer research : an official journal of the American Association for Cancer Research
  • Inhibition of Notch signaling reduces the stem-like population of breast cancer cells and prevents mammosphere formation. Grudzien, P.; Lo, S.; Albain, K. S.; Robinson, P.; Rajan, P.; Strack, P. R.; Golde, T. E.; Miele, L.; Foreman, K. E., Anticancer Research
  • Manganese superoxide dismutase polymorphism treatment-related toxicity and disease-free survival in SWOG 8897 clinical trial for breast cancer, Yao, S.; Barlow, W. E.; Albain, K. S.; Choi, J. Y.; Zhao, H.; Livingston, R. B.; Davis, W.; Rae, J. M.; Yeh, I. T.; Hutchins, L. F.; Ravdin, P. M.; Martino, S.; Lyss, A. P.; Osborne, C. K.; Abeloff, M. D.; Hortobagyi, G. N.; Hayes, D. F.; Ambrosone, C. B., Breast cancer research and treatment
  • Phase II selection design trial of concurrent chemotherapy and cetuximab versus chemotherapy followed by cetuximab in advanced-stage non-small-cell lung cancer: Southwest Oncology Group study S0342 Herbst, R. S.; Kelly, K.; Chansky, K.; Mack, P. C.; Franklin, W. A.; Hirsch, F. R.; Atkins, J. N.; Dakhil, S. R.; Albain, K. S.; Kim, E. S.; Redman, M.; Crowley, J. J.; Gandara, D. R., Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Proceedings of the first global workshop on breast cancer: pathways to the evaluation and clinical development of novel agents for breast cancer Albain, K. S.; Carey, L.; Gradishar, W. J.; Gralow, J. R.; Lipton, A.; Rugo, H.; Tripathy, D.; Peck, S.; Abair, T.; Pegram, M., Clinical Breast Cancer
  • Prognostic and predictive value of the 21-gene recurrence score assay in postmenopausal women with node-positive oestrogen-receptor-positive breast cancer on chemotherapy: a retrospective analysis of a randomised trial., Albain, K. S.; Barlow, W. E.; Shak, S.; Hortobagyi, G. N.; Livingston, R. B.; Yeh, I. T.; Ravdin, P.; Bugarini, R.; Baehner, F. L.; Davidson, N. E.; Sledge, G. W.; Winer, E. P.; Hudis, C.; Ingle, J. N.; Perez, E. A.; Pritchard, K. I.; Shepherd, L.; Gralow, J. R.; Yoshizawa, C.; Allred, D. C.; Osborne, C. K.; Hayes, D. F., Lancet Oncology
  • Prospective multicenter study of the impact of the 21-gene recurrence score assay on medical oncologist and patient adjuvant breast cancer treatment selection. Lo, S. S.; Mumby, P. B.; Norton, J.; Rychlik, K.; Smerage, J.; Kash, J.; Chew, H. K.; Gaynor, E. R.; Hayes, D. F.; Epstein, A.; Albain, K. S., Journal of Clinical Oncology
  • Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012) Slovak, M. L.; Bedell, V.; Lew, D.; Albain, K. S.; Ellis, G. K.; Livingston, R. B.; Martino, S.; Perez, E. A.; Hortobagyi, G. N.; Sher, D.; Stock, W., Breast cancer research and treatment
  • Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive node-positive breast cancer: a phase 3, open-label, randomised controlled trial, Albain, K. S.; Barlow, W. E.; Ravdin, P. M.; Farrar, W. B.; Burton, G. V.; Ketchel, S. J.; Cobau, C. D.; Levine, E. G.; Ingle, J. N.; Pritchard, K. I.; Lichter, A. S.; Schneider, D. J.; Abeloff, M. D.; Henderson, I. C.; Muss, H. B.; Green, S. J.; Lew, D.; Livingston, R. B.; Martino, S.; Osborne, C. K., Lancet
  • Assessing breast cancer risk and providing treatment recommendations: immediate impact of an educational session Gabram, S. G.; Dougherty, T.; Albain, K. S.; Klein, K.; Mumby, P.; Lee, K.; Yao, K.; Krishnamachari, B.; Salibay, C. J.; Lund, M. J., The breast journal
  • Bortezomib plus gemcitabine/carboplatin as first-line treatment of advanced non-small cell lung cancer: a phase II Southwest Oncology Group Study (S0339) Davies, A. M.; Chansky, K.; Lara, P. N., Jr; Gumerlock, P. H.; Crowley, J.; Albain, K. S.; Vogel, S. J.; Gandara, D. R.; Southwest Oncology Group, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
  • Endocrine Therapy with Selective Estrogen Receptor Modulators (SERMs) and Aromatase Inhibitors in the Prevention and Adjuvant Therapy Settings Lo, S. S.; Pritchard, K. I.; Robinson, P.; Albain, K. S., Cancer treatment and research
  • International guidelines for management of metastatic breast cancer: combination vs sequential single-agent chemotherapy Cardoso, F.; Bedard, P. L.; Winer, E. P.; Pagani, O.; Senkus-Konefka, E.; Fallowfield, L. J.; Kyriakides, S.; Costa, A.; Cufer, T.; Albain, K. S.; ESO-MBC Task Force, Journal of the National Cancer Institute
  • Lung cancer outcomes in women. Shafer, D.; Albain, K., Seminars in oncology
  • Myeloperoxidase genotypes and enhanced efficacy of chemotherapy for early-stage breast cancer in SWOG-8897 Ambrosone, C. B.; Barlow, W. E.; Reynolds, W.; Livingston, R. B.; Yeh, I. T.; Choi, J. Y.; Davis, W.; Rae, J. M.; Tang, L.; Hutchins, L. R.; Ravdin, P. M.; Martino, S.; Osborne, C. K.; Lyss, A. P.; Hayes, D. F.; Albain, K. S., Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Nitric oxide synthase variants and disease-free survival among treated and untreated breast cancer patients in a Southwest Oncology Group clinical trial Choi, J. Y.; Barlow, W. E.; Albain, K. S.; Hong, C. C.; Blanco, J. G.; Livingston, R. B.; Davis, W.; Rae, J. M.; Yeh, I. T.; Hutchins, L. F.; Ravdin, P. M.; Martino, S.; Lyss, A. P.; Osborne, C. K.; Abeloff, M. D.; Hayes, D. F.; Ambrosone, C. B., Clinical cancer research : an official journal of the American Association for Cancer Research
  • Outcome of patients with early-stage breast cancer treated with doxorubicin-based adjuvant chemotherapy as a function of HER2 and TOP2A status Tubbs, R.; Barlow, W. E.; Budd, G. T.; Swain, E.; Porter, P.; Gown, A.; Yeh, I. T.; Sledge, G.; Shapiro, C.; Ingle, J.; Haskell, C.; Albain, K. S.; Livingston, R.; Hayes, D. F., Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Phase II studies of gemcitabine and cisplatin in heavily and minimally pretreated metastatic breast cancer Chew, H. K.; Doroshow, J. H.; Frankel, P.; Margolin, K. A.; Somlo, G.; Lenz, H. J.; Gordon, M.; Zhang, W.; Yang, D.; Russell, C.; Spicer, D.; Synold, T.; Bayer, R.; Hantel, A.; Stiff, P. J.; Tetef, M. L.; Gandara, D. R.; Albain, K. S., Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Prediction of adjuvant chemotherapy benefit in endocrine responsive early breast cancer using multigene assays, Albain, K. S.; Paik, S.; van't Veer, L., Breast
  • Racial disparities in cancer survival among randomized clinical trials patients of the Southwest Oncology Group Albain, K. S.; Unger, J. M.; Crowley, J. J.; Coltman, C. A., Jr; Hershman, D. L., Journal of the National Cancer Institute
  • Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial Albain, K. S.; Swann, R. S.; Rusch, V. W.; Turrisi, A. T., 3rd; Shepherd, F. A.; Smith, C.; Chen, Y.; Livingston, R. B.; Feins, R. H.; Gandara, D. R.; Fry, W. A.; Darling, G.; Johnson, D. H.; Green, M. R.; Miller, R. C.; Ley, J.; Sause, W. T.; Cox, J. D., Lancet
  • A phase II study of cisplatin preceded by a 12-h continuous infusion of concurrent hydroxyurea and cytosine arabinoside (Ara-C) for adult patients with malignant gliomas (Southwest Oncology Group S9149). Swinnen, L. J.; Rankin, C.; Carraway, H.; Albain, K. S.; Townsend, J. J.; Budd, G. T.; Kish, J. A.; Rivkin, S. E.; Blumenthal, D. T., Journal of neuro-oncology
  • Cross-talk between notch and the estrogen receptor in breast cancer suggests novel therapeutic approaches Rizzo, P.; Miao, H.; D'Souza, G.; Osipo, C.; Song, L. L.; Yun, J.; Zhao, H.; Mascarenhas, J.; Wyatt, D.; Antico, G.; Hao, L.; Yao, K.; Rajan, P.; Hicks, C.; Siziopikou, K.; Selvaggi, S.; Bashir, A.; Bhandari, D.; Marchese, A.; Lendahl, U.; Qin, J. Z.; Tonetti, D. A.; Albain, K.; Nickoloff, B. J.; Miele, L., Cancer research
  • Gemcitabine plus Paclitaxel versus Paclitaxel monotherapy in patients with metastatic breast cancer and prior anthracycline treatment. Albain, K. S.; Nag, S. M.; Calderillo-Ruiz, G.; Jordaan, J. P.; Llombart, A. C.; Pluzanska, A.; Rolski, J.; Melemed, A. S.; Reyes-Vidal, J. M.; Sekhon, J. S.; Simms, L.; O'Shaughnessy, J., Journal of Clinical Oncology
  • Late cardiac effects of adjuvant chemotherapy in breast cancer survivors treated on Southwest Oncology Group protocol s8897 Ganz, P. A.; Hussey, M. A.; Moinpour, C. M.; Unger, J. M.; Hutchins, L. F.; Dakhil, S. R.; Giguere, J. K.; Goodwin, J. W.; Martino, S.; Albain, K. S., Journal of Clinical Oncology
  • Phase III randomized placebo-controlled trial of two doses of megestrol acetate as treatment for menopausal symptoms in women with breast cancer: Southwest Oncology Group Study 9626. Goodwin, J. W.; Green, S. J.; Moinpour, C. M.; Bearden, J. D., 3rd; Giguere, J. K.; Jiang, C. S.; Lippman, S. M.; Martino, S.; Albain, K. S., Journal of Clinical Oncology
  • Phase III trial of maintenance gefitinib or placebo after concurrent chemoradiotherapy and docetaxel consolidation in inoperable stage III non-small-cell lung cancer: SWOG S0023 Kelly, K.; Chansky, K.; Gaspar, L. E.; Albain, K. S.; Jett, J.; Ung, Y. C.; Lau, D. H.; Crowley, J. J.; Gandara, D. R., Journal of Clinical Oncology
  • Prevalence of secondary causes of bone loss among breast cancer patients with osteopenia and osteoporosis. Camacho, P. M.; Dayal, A. S.; Diaz, J. L.; Nabhan, F. A.; Agarwal, M.; Norton, J. G.; Robinson, P. A.; Albain, K. S., Journal of Clinical Oncology
  • Impact of a peer-delivered telephone intervention for women experiencing a breast cancer recurrence. Gotay, C. C.; Moinpour, C. M.; Unger, J. M.; Jiang, C. S.; Coleman, D.; Martino, S.; Parker, B. J.; Bearden, J. D.; Dakhil, S.; Gross, H. M.; Lippman, S.; Albain, K. S., Journal of Clinical Oncology
  • Acute lung injury associated with vinorelbine. Tanvetyanon, T.; Garrity, E. R.; Albain, K. S., Journal of Clinical Oncology
  • Clinical factors used to support prophylactic mastectomy for a male BRCA2 mutation carrier. Guiahi, M.; Gabram, S. G.; Albain, K. S.; Camacho, P. M.; Krishnamachari, B.; Rajan, P., Surgery
  • Correlation of nipple aspiration and ductal lavage cytology with histopathologic findings for patients before scheduled breast biopsy examination. West, K. E.; Wojcik, E. M.; Dougherty, T. A.; Siziopikou, K. P.; Albain, K. S.; Gabram, S. G., American Journal of Surgery
  • Impact of the year 2000 Medicare policy change on older patient enrollment to cancer clinical trials. Unger, J. M.; Coltman, C. A., Jr; Crowley, J. J.; Hutchins, L. F.; Martino, S.; Livingston, R. B.; Macdonald, J. S.; Blanke, C. D.; Gandara, D. R.; Crawford, E. D.; Albain, K. S., Journal of Clinical Oncology
  • Long-term survival with concurrent chemoradiation therapy followed by consolidation docetaxel in stage IIIB non-small-cell lung cancer: a phase II Southwest Oncology Group Study (S9504). Gandara, D. R.; Chansky, K.; Albain, K. S.; Gaspar, L. E.; Lara, P. N., Jr; Kelly, K.; Crowley, J.; Livingston, R., Clinical Lung Cancer
  • New developments in the epidemiology of cancer prognosis: traditional and molecular predictors of treatment response and survival Ambrosone, C. B.; Rebbeck, T. R.; Morgan, G. J.; Albain, K. S.; Calle, E. E.; Evans, W. E.; Hayes, D. F.; Kushi, L. H.; McLeod, H. L.; Rowland, J. H.; Ulrich, C. M., Cancer Epidemiology, Biomarkers & Prevention
  • p27(Kip1) and cyclin E expression and breast cancer survival after treatment with adjuvant chemotherapy Porter, P. L.; Barlow, W. E.; Yeh, I. T.; Lin, M. G.; Yuan, X. P.; Donato, E.; Sledge, G. W.; Shapiro, C. L.; Ingle, J. N.; Haskell, C. M.; Albain, K. S.; Roberts, J. M.; Livingston, R. B.; Hayes, D. F., Journal of the National Cancer Institute
  • PIONEER: a phase III randomized trial of paclitaxel poliglumex versus paclitaxel in chemotherapy-naive women with advanced-stage non-small-cell lung cancer and performance status of 2. Albain, K. S.; Belani, C. P.; Bonomi, P.; O'Byrne, K. J.; Schiller, J. H.; Socinski, M., Clinical Lung Cancer
  • Randomized phase III study of trastuzumab paclitaxel, and carboplatin compared with trastuzumab and paclitaxel in women with HER-2-overexpressing metastatic breast cancer., Robert, N.; Leyland-Jones, B.; Asmar, L.; Belt, R.; Ilegbodu, D.; Loesch, D.; Raju, R.; Valentine, E.; Sayre, R.; Cobleigh, M.; Albain, K.; McCullough, C.; Fuchs, L.; Slamon, D., Journal of Clinical Oncology
  • Current standards and ongoing controversies in the management of locally advanced non-small cell lung cancer West, H.; Albain, K. S., Seminars in oncology
  • Improving survival and reducing toxicity with chemotherapy in advanced non-small cell lung cancer : a realistic goal? Blackhall, F. H.; Shepherd, F. A.; Albain, K. S., Treatments in respiratory medicine
  • Multimodality therapy for stage III non-small-cell lung cancer.[erratum appears in J Clin Oncol. 2005 Oct 20;23(30):7763] Farray, D.; Mirkovic, N.; Albain, K. S., Journal of Clinical Oncology
  • Reducing the global breast cancer burden: the importance of patterns of care research Albain, K. S.; de la Garza Salazar, J.; Pienkowski, T.; Aapro, M.; Bergh, J.; Caleffi, M.; Coleman, R.; Eiermann, W.; Icli, F.; Pegram, M.; Piccart, M.; Snyder, R.; Toi, M.; Hortobagyi, G. N., Clinical Breast Cancer
  • Sequencing of tamoxifen and radiotherapy after breast-conserving surgery in early-stage breast cancer Pierce, L. J.; Hutchins, L. F.; Green, S. R.; Lew, D. L.; Gralow, J. R.; Livingston, R. B.; Osborne, C. K.; Albain, K. S., Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • The global breast cancer burden: variations in epidemiology and survival Hortobagyi, G. N.; de la Garza Salazar, J.; Pritchard, K.; Amadori, D.; Haidinger, R.; Hudis, C. A.; Khaled, H.; Liu, M. C.; Martin, M.; Namer, M.; O'Shaughnessy, J. A.; Shen, Z. Z.; Albain, K. S.; ABREAST Investigators, Clinical Breast Cancer
  • Therapeutic strategies for combined-modality therapy of locally advanced non-small-cell lung cancer: rationale for consolidation docetaxel therapy Gandara, D. R.; Vallieres, E.; Gaspar, L. E.; Kelly, K.; Albain, K. S.; Herbst, R. S., Jr; Lara, P. N., Jr; Mack, P.; Gumerlock, P. H.; Crowley, J. J., Clinical Lung Cancer
  • Time from treatment to subsequent diagnosis of brain metastases in stage III non-small-cell lung cancer: a retrospective review by the Southwest Oncology Group Gaspar, L. E.; Chansky, K.; Albain, K. S.; Vallieres, E.; Rusch, V.; Crowley, J. J.; Livingston, R. B.; Gandara, D. R., Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Adjuvant chemotherapy for lymph node-negative estrogen receptor-negative breast cancer: a tale of three trials, Albain, K. S., Journal of the National Cancer Institute
  • Breast cancer chemoprevention phase I evaluation of biomarker modulation by arzoxifene a third generation selective estrogen receptor modulator, Fabian, C. J.; Kimler, B. F.; Anderson, J.; Tawfik, O. W.; Mayo, M. S.; Burak, W. E., Jr; O'Shaughnessy, J. A.; Albain, K. S.; Hyams, D. M.; Budd, G. T.; Ganz, P. A.; Sauter, E. R.; Beenken, S. W.; Grizzle, W. E.; Fruehauf, J. P.; Arneson, D. W.; Bacus, J. W.; Lagios, M. D.; Johnson, K. A.; Browne, D., Clinical cancer research : an official journal of the American Association for Cancer Research
  • Gemcitabine in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: a phase II California cancer consortium trial Lara, P. N., Jr; Gumerlock, P. H.; Mack, P. C.; Lau, D. H.; Gandour-Edwards, R.; Edelman, M. J.; Albain, K. S.; Law, L. Y.; Longmate, J.; Frankel, P.; Reddy, G. P.; Israel, V.; Doroshow, J. H.; Gandara, D. R., Clinical Lung Cancer
  • Randomized phase II trial of sequential chemotherapy in advanced non-small cell lung cancer (SWOG 9806): carboplatin/gemcitabine followed by paclitaxel or cisplatin/vinorelbine followed by docetaxel Edelman, M. J.; Clark, J. I.; Chansky, K.; Albain, K.; Bhoopalam, N.; Weiss, G. R.; Giguere, J. K.; Kelly, K.; Crowley, J.; Gandara, D. R., Clinical cancer research : an official journal of the American Association for Cancer Research
  • The potential role of surgery after induction treatment Grunenwald, D. H.; Albain, K. S., SEMINARS IN RADIATION ONCOLOGY
  • American Society of Clinical Oncology 2003 update on the role of bisphosphonates and bone health issues in women with breast cancer Hillner, B. E.; Ingle, J. N.; Chlebowski, R. T.; Gralow, J.; Yee, G. C.; Janjan, N. A.; Cauley, J. A.; Blumenstein, B. A.; Albain, K. S.; Lipton, A.; Brown, S.; American Society of Clinical Oncology, Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Consolidation docetaxel after concurrent chemoradiotherapy in stage IIIB non-small-cell lung cancer: phase II Southwest Oncology Group Study S9504 Gandara, D. R.; Chansky, K.; Albain, K. S.; Leigh, B. R.; Gaspar, L. E.; Lara, P. N., Jr; Burris, H.; Gumerlock, P.; Kuebler, J. P.; Bearden, J. D., 3rd; Crowley, J.; Livingston, R.; Southwest Oncology Group, Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Efficacy of gefitinib an inhibitor of the epidermal growth factor receptor tyrosine kinase, in symptomatic patients with non-small cell lung cancer: a randomized trial, Kris, M. G.; Natale, R. B.; Herbst, R. S.; Lynch, T. J., Jr; Prager, D.; Belani, C. P.; Schiller, J. H.; Kelly, K.; Spiridonidis, H.; Sandler, A.; Albain, K. S.; Cella, D.; Wolf, M. K.; Averbuch, S. D.; Ochs, J. J.; Kay, A. C., JAMA : the journal of the American Medical Association
  • Induction treatment before surgery for non-small cell lung cancer Eberhardt, W. E.; Albain, K. S.; Pass, H.; Putnam, J. B.; Gregor, A.; Assamura, H.; Mornex, F.; Senan, S.; Belderbos, J.; Westeel, V.; Thomas, M.; Van Schil, P.; Vansteenkiste, J.; Manegold, C.; Mirimanoff, R. O.; Stuschke, M.; Pignon, J.; Rocmans, P.; Shepherd, F. A., Lung cancer (Amsterdam, Netherlands)
  • Quantification of chemotherapeutic target gene mRNA expression in human breast cancer biopsies: comparison of real-time reverse transcription-PCR vs. relative quantification reverse transcription-PCR utilizing DNA sequencer analysis of PCR products Juhasz, A.; Frankel, P.; Cheng, C.; Rivera, H.; Vishwanath, R.; Chiu, A.; Margolin, K.; Yen, Y.; Newman, E. M.; Synold, T.; Wilczynski, S.; Lenz, H. J.; Gandara, D.; Albain, K. S.; Longmate, J.; Doroshow, J. H., Journal of clinical laboratory analysis
  • Concurrent cisplatin etoposide, and chest radiotherapy in pathologic stage IIIB non-small-cell lung cancer: a Southwest Oncology Group phase II study, SWOG 9019, Albain, K. S.; Crowley, J. J.; Turrisi, A. T., 3rd; Gandara, D. R.; Farrar, W. B.; Clark, J. I.; Beasley, K. R.; Livingston, R. B., Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Positive immunohistochemistry in histologically negative sentinel noeds: affect on adjuvant therapy in early-stage breast cancer. Stradling, B.; Albain, K.; Siziopikou, K.; Wilcoxson, L.; Aranha, G. V.; Shayani, V.; Fisher, S.; Grabram, S., Surgical Rounds
  • Combined modality therapy for early stage operable and locally advanced potentially resectable non-small cell lung carcinoma Clark, J. I.; Albain, K. S., Cancer treatment and research
  • Gender and other survival predictors in patients with metastatic melanoma on Southwest Oncology Group trials Unger, J. M.; Flaherty, L. E.; Liu, P. Y.; Albain, K. S.; Sondak, V. K., Cancer
  • Pilot study of sequential vinorelbine and cisplatin followed by docetaxel for selected IIIB and stage IV non-small cell lung cancer Clark, J. I.; Kancharla, K.; Qamar, R.; Fisher, S.; Hantel, A.; Panganiban, J.; Millbrandt, L.; Albain, K. S., Lung cancer (Amsterdam, Netherlands)
  • American Society of Clinical Oncology guideline on the role of bisphosphonates in breast cancer. American Society of Clinical Oncology Bisphosphonates Expert Panel Hillner, B. E.; Ingle, J. N.; Berenson, J. R.; Janjan, N. A.; Albain, K. S.; Lipton, A.; Yee, G.; Biermann, J. S.; Chlebowski, R. T.; Pfister, D. G., Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • Behavioral science research in the cooperative group setting: the Southwest Oncology Group experience Gotay, C. C.; Moinpour, C. M.; Moody-Thomas, S.; Gritz, E. R.; Albain, K. S.; DeAntoni, E.; Hansen, L.; Ganz, P. A., Journal of the National Cancer Institute
  • Induction chemotherapy or chemoradiotherapy before surgery for non-small-cell lung cancer Albain, K. S., Current oncology reports